Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of brevicidine analog 22 in China, also supports custom service. Welcome to wholesale bulk high quality brevicidine analog 22 from our factory. Contact us for more details.
↵
| Description | Brevicidine analog 22 is a synthetic analog of the cyclic lipodepsipeptide brevicidine (molecular formula C78H118N18O17, molecular weight 1579.88 Da). The parent brevicidine is a 12-residue cyclic lipodepsipeptide with an N-terminal 4-methylhexanoyl fatty acid chain, containing multiple D-amino acids (D-Asn, D-Tyr, D-Trp, D-Orn), cyclized through a Thr9-Ser12 lactone bond, with a parent molecular weight of 1519.74 Da. Brevicidine family lipodepsipeptides exhibit selective antibacterial activity against Gram-negative bacteria, with a mechanism involving interaction with bacterial outer membrane lipopolysaccharide (LPS) and membrane permeability disruption. Analog 22 is a structurally optimized derivative of the parent; the specific amino acid sequence is per supplier COA. Widely used in anti-Gram-negative drug development, cyclic lipodepsipeptide structure-activity relationship studies and novel antibiotic scaffold exploration. |
| Structure type | Cyclic lipodepsipeptide (4-methylhexanoyl lipid chain, lactone cyclization) |
| Solubility | Soluble in DMSO, methanol, DMF |
| Storage | Powder at -20C, dry, protected from light |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| Brevicidine analog 22 | Brevicidine analog 22; optimized brevibacillus AMP | Antimicrobial peptide, Gram-negative targeting, antibiofilm, anti-resistant bacteria, anti-infection | Rationally optimized analog of brevicidine, retaining the rigid hairpin conformation via intramolecular disulfide bond; enhanced outer membrane penetration efficiency via tuned charge and amphipathicity; significantly more active against MDR Gram-negative bacteria than the parent peptide | C₆₀H₈₉N₁₉O₁₀S₂ | 1279.63 | ~1280.7 | Acetate | 12 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-BRVA22 | White powder | Store at -20°C, sealed, dry and protected from light. Aliquot for storage. | Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. | Stable for 7 days at 4°C. Soluble in dilute acetic acid and acidic buffers. Disulfide-stabilized conformation confers high protease resistance. Avoid strong reducing agents to prevent disulfide cleavage. | Stable for 2 years at -20°C, dry and protected from light. |
Functional Description
| Product Code | Frontend Short Summary (for search list display) | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-BRVA22 | Optimized brevicidine analog 22 with enhanced Gram-negative penetration | Brevicidine analog 22 is a rationally optimized variant of the parent peptide brevicidine, retaining the rigid hairpin conformation stabilized by an intramolecular disulfide bond. Tuned charge distribution and hydrophobic face improve outer membrane penetration efficiency. It shows several-fold higher bactericidal activity against MDR E. coli and K. pneumoniae than the parent, inhibits biofilm formation and maturation, and eradicates persister cells. | MDR Gram-negative infections, AMP optimization, biofilm eradication, anti-infective drug development, disulfide cyclic peptides | Gram-negative outer membrane LPS penetration; inner membrane depolarization; biofilm matrix disruption |
Hot Tags: brevicidine analog 22, China brevicidine analog 22 manufacturers, suppliers, factory, 143459-88-5, 3032621-32-9, CAS 188713 80 6, CAS 3032621 32 9, CAS 79404 91 4, CP7-FP13-2
